Schedule 13D ownership disclosure
SYNTA PHARMACEUTICALS CORP
Security class unavailable · CUSIP: 87162T206
Event date: 2015-12-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-15-008614
- Form type
- SC 13D
- Filer
- CAXTON CORP
- CIK
- CIK 1388551
- Filed
- Dec 09, 2015
- Reporting period
- Dec 08, 2015
- Description
- Schedule 13D beneficial ownership